Harrington, J., Hellkamp, A. S., Alexander, J. H., Mehran, R., Granger, C. B., Goodman, S. G., … Lopes, R. D. (2022). Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial. In CIRCULATION (Vol. 146).

Harrington, Josephine, Anne S. Hellkamp, John H. Alexander, Roxana Mehran, Christopher B. Granger, Shaun G. Goodman, Ron Aronson, Stephan Windecker, and Renato D. Lopes. “Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial.” In CIRCULATION, Vol. 146, 2022.

Harrington J, Hellkamp AS, Alexander JH, Mehran R, Granger CB, Goodman SG, et al. Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial. In: CIRCULATION. 2022.

Harrington, Josephine, et al. “Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial.” CIRCULATION, vol. 146, 2022.

Harrington J, Hellkamp AS, Alexander JH, Mehran R, Granger CB, Goodman SG, Aronson R, Windecker S, Lopes RD. Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial. CIRCULATION. 2022.